These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 12623126)
1. Opposing mechanisms of NADPH-cytochrome P450 oxidoreductase regulation by peroxisome proliferators. Fan LQ; Coley J; Miller RT; Cattley RC; Corton JC Biochem Pharmacol; 2003 Mar; 65(6):949-59. PubMed ID: 12623126 [TBL] [Abstract][Full Text] [Related]
2. Altered expression of the carboxylesterases ES-4 and ES-10 by peroxisome proliferator chemicals. Poole M; Bridgers K; Alexson SE; Corton JC Toxicology; 2001 Aug; 165(2-3):109-19. PubMed ID: 11522369 [TBL] [Abstract][Full Text] [Related]
3. Regulation of phase I and phase II steroid metabolism enzymes by PPAR alpha activators. Fan LQ; You L; Brown-Borg H; Brown S; Edwards RJ; Corton JC Toxicology; 2004 Nov; 204(2-3):109-21. PubMed ID: 15388238 [TBL] [Abstract][Full Text] [Related]
4. Sustained formation of alpha-(4-pyridyl-1-oxide)-N-tert-butylnitrone radical adducts in mouse liver by peroxisome proliferators is dependent upon peroxisome proliferator-activated receptor-alpha, but not NADPH oxidase. Woods CG; Burns AM; Maki A; Bradford BU; Cunningham ML; Connor HD; Kadiiska MB; Mason RP; Peters JM; Rusyn I Free Radic Biol Med; 2007 Feb; 42(3):335-42. PubMed ID: 17210446 [TBL] [Abstract][Full Text] [Related]
5. Post-transcriptional regulation of hepatic NADPH-cytochrome P450 reductase by thyroid hormone: independent effects on poly(A) tail length and mRNA stability. Liu D; Waxman DJ Mol Pharmacol; 2002 May; 61(5):1089-96. PubMed ID: 11961126 [TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferators alter the expression of estrogen-metabolizing enzymes. Corton JC; Bocos C; Moreno ES; Merritt A; Cattley RC; Gustafsson JA Biochimie; 1997; 79(2-3):151-62. PubMed ID: 9209713 [TBL] [Abstract][Full Text] [Related]
7. PPARalpha activators down-regulate CYP2C7, a retinoic acid and testosterone hydroxylase. Fan LQ; Brown-Borg H; Brown S; Westin S; Mode A; Corton JC Toxicology; 2004 Oct; 203(1-3):41-8. PubMed ID: 15363580 [TBL] [Abstract][Full Text] [Related]
8. Characterization of peroxisome proliferator-activated receptor alpha--independent effects of PPARalpha activators in the rodent liver: di-(2-ethylhexyl) phthalate also activates the constitutive-activated receptor. Ren H; Aleksunes LM; Wood C; Vallanat B; George MH; Klaassen CD; Corton JC Toxicol Sci; 2010 Jan; 113(1):45-59. PubMed ID: 19850644 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of thyroid hormone effects on liver P450 reductase translation. Apletalina EV; Li HC; Waxman DJ Arch Biochem Biophys; 2003 Jan; 409(1):172-9. PubMed ID: 12464256 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation of cytochrome P450 2C family members and positive acute-phase response gene expression by peroxisome proliferator chemicals. Corton JC; Fan LQ; Brown S; Anderson SP; Bocos C; Cattley RC; Mode A; Gustafsson JA Mol Pharmacol; 1998 Sep; 54(3):463-73. PubMed ID: 9730905 [TBL] [Abstract][Full Text] [Related]
11. Hepatic expression of acute-phase protein genes during carcinogenesis induced by peroxisome proliferators. Anderson SP; Cattley RC; Corton JC Mol Carcinog; 1999 Dec; 26(4):226-38. PubMed ID: 10569800 [TBL] [Abstract][Full Text] [Related]
12. Transcriptional induction of hepatic NADPH: cytochrome P450 oxidoreductase by thyroid hormone. Li HC; Liu D; Waxman DJ Mol Pharmacol; 2001 May; 59(5):987-95. PubMed ID: 11306680 [TBL] [Abstract][Full Text] [Related]
13. Regulation of CYP4A expression in rat by dehydroepiandrosterone and thyroid hormone. Webb SJ; Xiao GH; Geoghegan TE; Prough RA Mol Pharmacol; 1996 Feb; 49(2):276-87. PubMed ID: 8632760 [TBL] [Abstract][Full Text] [Related]
14. Conjugated linoleic acid activates peroxisome proliferator-activated receptor alpha and beta subtypes but does not induce hepatic peroxisome proliferation in Sprague-Dawley rats. Moya-Camarena SY; Van den Heuvel JP; Belury MA Biochim Biophys Acta; 1999 Jan; 1436(3):331-42. PubMed ID: 9989264 [TBL] [Abstract][Full Text] [Related]
16. Effects of peroxisome proliferators on antioxidant enzymes and antioxidant vitamins in rats and hamsters. O'Brien ML; Twaroski TP; Cunningham ML; Glauert HP; Spear BT Toxicol Sci; 2001 Apr; 60(2):271-8. PubMed ID: 11248139 [TBL] [Abstract][Full Text] [Related]
17. Regulation of peroxisome proliferator-activated receptor-alpha mRNA in rat liver. Sterchele PF; Sun H; Peterson RE; Vanden Heuvel JP Arch Biochem Biophys; 1996 Feb; 326(2):281-9. PubMed ID: 8611035 [TBL] [Abstract][Full Text] [Related]
18. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. Marsman DS; Cattley RC; Conway JG; Popp JA Cancer Res; 1988 Dec; 48(23):6739-44. PubMed ID: 3180084 [TBL] [Abstract][Full Text] [Related]
19. Expression of the mRNA encoding truncated PPAR alpha does not correlate with hepatic insensitivity to peroxisome proliferators. Hanselman JC; Vartanian MA; Koester BP; Gray SA; Essenburg AD; Rea TJ; Bisgaier CL; Pape ME Mol Cell Biochem; 2001 Jan; 217(1-2):91-7. PubMed ID: 11269670 [TBL] [Abstract][Full Text] [Related]
20. Thyroid regulation of NADPH:cytochrome P450 oxidoreductase: identification of a thyroid-responsive element in the 5'-flank of the oxidoreductase gene. O'Leary KA; Li HC; Ram PA; McQuiddy P; Waxman DJ; Kasper CB Mol Pharmacol; 1997 Jul; 52(1):46-53. PubMed ID: 9224811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]